title: Hyperglycemic management after solid organ transplantation.
abstract: Hyperglycemia after solid organ transplantation increases the risk for wound infection, poor healing time, graft rejection, and graft loss. In patients without a history of diabetes, uncontrolled hyperglycemia increases the risk for advancement to diabetes mellitus. Controlling hyperglycemia can reduce the prevalence of new-onset diabetes after transplantation. This article discusses the current literature concerning blood glucose management after solid organ transplantation, the issues surrounding hyperglycemia in the patient with a solid organ transplant, and how to manage hyperglycemia after solid organ transplant.
authors: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA. jlrollin@mdanderson.org
authors: Johnny L
authors: JL
authors: Rollins
mesh_terms: D003422:Critical Care; D005938:Glucocorticoids / Q000008:administration & dosage; D006084:Graft Rejection / Q000453:epidemiology; D006760:Hospitalization; D006801:Humans; D006943:Hyperglycemia / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D007328:Insulin / Q000008:administration & dosage / Q000493:pharmacokinetics; D008991:Monitoring, Physiologic; D016377:Organ Transplantation; D012307:Risk Factors; D014945:Wound Healing / Q000502:physiology*
chemical_list: D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007328:Insulin